Application of plasma exosome miR-455-3p as early liver cancer diagnostic marker
A technology for early-stage liver cancer and exosomes, which is applied in the fields of biotechnology and medicine to achieve the effects of accurate quantification, broad market application prospects, and easy clinical development.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0046] 1. Research objects: 22 patients with early liver cancer from Beijing You'an Hospital Affiliated to Capital Medical University from July 2016 to December 2017 were selected as the research group. Among them, there were 10 males and 12 females. Aged 41 to 76 years old, with an average of (60.1±10.6) years old. The diagnostic criteria for early liver cancer are based on the "Primary Liver Cancer Diagnosis and Treatment Standards (2017 Edition)" issued by the National Health and Family Planning Commission. All liver cancer patients whose plasma is collected have a tumor volume of ≤5 cm and are single tumors. Chronic HBV infection group included 25 patients, including 13 males and 12 females, aged 40 to 65 years, with an average of (52.2±9.7) years old. The diagnostic criteria for chronic hepatitis B are based on the "Diagnostic Criteria for Chronic Hepatitis B (2015 Edition)" issued by the Infectious Diseases Branch of the Chinese Medical Association's Hepatology Branch. ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com